Description

In this episode, approval of an Ad5 vectored SARS-CoV-2 vaccine for the military in China, description and clinical trials of a Novavax vaccine joining Operation Warp Speed, prevalence of SARS-CoV-2 in Spain, shedding and transmissibility of the virus, and listener email.

Hosts: Vincent Racaniello, Rich Condit, and Kathy Spindler

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• China approves COVID-19 vaccine for military (CNN)
• Ad5-vectored COVID-19 vaccine phase I results (Lancet)
• US pays $1.6 billion for Novavax vaccine (NY Times)
• CEPI awards $388 million to Novavax (Novavax)
• HHS on Novavax vaccine (HHS)
• Novavax phase I/II trials (GlobeNewswire)
• Prevalence of SARS-CoV-2 in Spain (Lancet)
• Shedding and transmissibility of SARS-CoV-2 (Nature)
• Letters read on TWiV 637
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your virology questions and comments to twiv@microbe.tv